The largest database of trusted experimental protocols

Ampicillin sulbactam

Manufactured by Thermo Fisher Scientific
Sourced in United Kingdom, United States

Ampicillin-sulbactam is a combination antibiotic medication used in the treatment of various bacterial infections. It consists of the antibiotic ampicillin and the beta-lactamase inhibitor sulbactam. Ampicillin-sulbactam is primarily used to treat infections caused by susceptible bacteria.

Automatically generated - may contain errors

30 protocols using ampicillin sulbactam

1

Antimicrobial Susceptibility Testing of Pathogens

Check if the same lab product or an alternative is used in the 5 most similar protocols
To test antibiotic resistance in Campylobacter spp., the broth microdilution method was used with 5 % sheep blood. For all other pathogens, antimicrobial susceptibilities were determined by the agar dilution method according to the Clinical and Laboratory Standards Institute (CLSI) Guidelines, 2015 [20 ]. All isolates of Salmonella spp. were tested for their minimum inhibitory concentrations (MICs) of ampicillin, ampicillin-sulbactam, ceftriaxone, cefotaxime, nalidixic acid, ciprofloxacin, levofloxacin, co-trimoxazole, azithromycin, chloramphenicol and tetracycline (Oxoid); DEC were tested for ampicillin, ampicillin-sulbactam, cefotaxime, ciprofloxacin, levofloxacin, chloramphenicol, tetracycline, cefazolin, cefuroxime, imipenem, amikacin and gentamicin (Oxoid); Campylobacter spp. were tested for ciprofloxacin, azithromycin, tetracycline, erythromycin and doxycycline (Oxoid); and Aeromonas spp. were tested for cefotaxime, ciprofloxacin, levofloxacin, co-trimoxazole, chloramphenicol, tetracycline, cefazolin, cefuroxime, imipenem, amikacin and gentamicin (Oxoid). ATCC 25922, 35218, 700603 and 27853 were used as quality control strains. Antibiotic susceptibility was interpreted according to CLSI guidelines, 2015 [20 ].
+ Open protocol
+ Expand
2

Antibiotic Resistance Profile of Bacterial Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial susceptibility profiles of the isolates were determined using the disk diffusion method according to the standard procedures of the Clinical and Laboratory Standards Institute (CLSI, 2013 ). Escherichia coli (ATCC25922) (Microbiologics, USA) was used as the quality control strain. The following 17 antibiotic discs (Oxoid) were used: amikacin, amoxicillin+clavulanic acid, ampicillin+sulbactam, azithromycin, cefepime, cefixime, cefotaxime, cefoxitin, cefperazone, ceftazidime, ceftriaxone, chloramphenicol, gentamycin, imipenem, levofloxacin, meropenem, and trimethoprim-sulphamethexazole. MDR was defined according to the guidelines of the European Society of Clinical Microbiology and Infectious Diseases (Magiorakos et al., 2012 (link)).
+ Open protocol
+ Expand
3

Rapid Antimicrobial Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A modification of the standard disk diffusion method (rAST) was evaluated for the detection of antimicrobial resistance. The rAST followed CLSI standards in all aspects, except for the inoculum preparation. CLSI guideline recommends preparing the inoculum for AST with a direct suspension of isolated colonies selected from 18–24 h agar plate incubation [6 ]. In this study, we used colonies selected from a rapid culture grown (4–6 h agar plate incubation). The inoculum was prepared from the rapid culture grown on a 150 mm Mueller–Hinton Agar (bioMérieux, France), and then, disks were applied and plates incubated at 35°C ± 1° and incubated for 18 h. The following antimicrobial agents were evaluated for GN: amikacin 30 μg, amoxicillin-clavulanate 20/10 μg, ampicillin 10 μg, ampicillin-sulbactam 10/10 μg, cefepime 30 μg, ceftazidime 30 μg, cefuroxime 30 μg, ciprofloxacin 5 μg, gentamicin 10 μg, meropenem 10 μg, piperacillin-tazobactam 100/10 μg, and trimethoprim-sulfamethoxazole 23.75/1.25 μg (Oxoid®, Thermo-Fisher, USA). For GP, cefoxitin 30 μg, clarithromycin 15 μg, clindamycin 2 μg, doxycycline 30 μg, erythromycin 15 μg, gentamicin 10 μg, levofloxacin 5 μg, rifampicin 5 μg, and trimethoprim-sulfamethoxazole 23.75/1.25 μg (Oxoid®) were evaluated. The inhibition zones were analyzed after 18–24 h, and the results were interpreted by CLSI proposed breakpoints [6 ].
+ Open protocol
+ Expand
4

Antibiotic Susceptibility of Cronobacter

Check if the same lab product or an alternative is used in the 5 most similar protocols
Based on the instructions of the Clinical and Laboratory Standards Institute [44 ], the Kirby–Bauer diffusion method was used to evaluate the antimicrobial agents (AMs) susceptibilities of Cronobacter isolates by diluting antibiotics and analyzing the sensitivities of the disks displayed in Mueller–Hinton agar (Huankai). A total of 16 antimicrobial agents (Oxoid, Hampshire, United Kingdom) were detected in this experiment: ampicillin (AMP, 10 μg), ampicillin/sulbactam (SAM, 10 μg), cefepime (FEP, 30 μg), ceftriaxone (CRO, 30 μg), cefazolin (KZ, 30 μg), cephalothin (KF, 30 μg), gentamicin (CN, 10 μg), tobramycin (TOB, 10 μg), amikacin (AMK, 30 μg), ciprofloxacin (CIP, 5 μg), imipenem (IPM, 10 μg), trimethoprim/sulfameth-oxazole (SXT, 25 μg), aztreonam (ATM, 30 μg), amoxicillin-clavulanic acid (AMC, 30 μg), chloramphenicol (C, 30 μg), and tetracycline (TE, 30 μg). We characterized the susceptibilities of the analyzed isolates after 24 h at 37 °C by measuring the inhibition region and illuminating the diameters according to the guidelines.
+ Open protocol
+ Expand
5

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Susceptibility testing was performed by Kirby Bauer disk diffusion method using 22 antibiotics: amikacin, ampicillin, cefpodoxime, ceftazidime, ceftriaxone, cefuroxime, ciprofloxacin, ertapenem, imipenem, nalidixic acid, nitrofurantoin, tetracycline, trimethoprim/sulfamethoxazole (Becton Dickinson, NJ), ampicillin-sulbactam, aztreonam, cefazoline, cefepime, cefotaxime, ceftiofur, chloramphenicol, kanamycin, and streptomycin (Oxoid), according to the Clinical and Laboratory Standards Institute, CLSI.18 ESCs and ciprofloxacin-resistant isolates were selected and cryopreserved for further analysis. Multiresistance was defined as the resistance to three or more structural classes of antibiotics19 (link) and M100 from CLSI (30th edition, 2020) was used for interpretation and antimicrobial class classification (Glossary I).20 Isolates showing an intermediate resistant pattern were included in the resistant group for the analysis of antibiotic susceptibility but excluded from the minimal inhibitory concentration (MIC) assays. MICs were performed manually using the microdilution method on isolates that showed resistance to cefotaxime, ciprofloxacin, and nalidixic acid as recommended by CLSI.21 Concentrations from 0.125 (μg/mL) to 256 (μg/mL) were evaluated for each antibiotic.
+ Open protocol
+ Expand
6

Antibiotic Susceptibility Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The susceptibility of all 74 isolates towards 17 different antibiotics was determined using the standard disc diffusion technique and the results were interpreted according to the guidelines of the Clinical and Laboratory Standards Institute 2018 (CLSI 2018 ). The antibiotics used were imipenem, meropenem, aztreonam, piperacillin, piperacillin/tazobactam, ampicillin/sulbactam, ceftazidime, cefepime, cefotaxime, ceftriaxone, tetracycline, doxycycline, amikacin, gentamicin, ciprofloxacin, levofloxacin, and sulphamethoxazole/trimethoprim (Oxoid Ltd, England).
+ Open protocol
+ Expand
7

Antimicrobial Susceptibilities of Enterobacterales

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antimicrobial susceptibilities of Enterobacterales against 17 antimicrobial agents were detected by adopting the Clinical and Laboratory Standards Institute [CLSI] recommendations (Clinical and Laboratory Standards Institute [CLSI], 2020 ). The examined antimicrobials (Oxoid, Cambridge, UK) were penicillins [amoxicillin (25 μg), amoxicillin-clavulanic acid (20/10 μg), ampicillin (10 μg), ampicillin-sulbactam (10/10 mg)], cephalosporins [cefoxitin (30 μg), ceftriaxone (30 μg), cefepime (30 μg)], carbapenems [imipenem (10 μg)], fluoroquinolones [ciprofloxacin (5 μg)], aminoglycosides [gentamicin (10 μg), amikacin (30 μg)], sulfonamides [trimethoprim-sulfamethoxazole (1.25/23.75 μg)], macrolides [erythromycin (15 μg)], tetracyclines [doxycycline (30 μg)], chloramphenicol [chloramphenicol (30 μg)], monobactam [aztreonam (10 μg)], and glycylcycline [tigecycline (15 μg)]. The multiple antibiotic resistance (MAR) indices were assessed according to Tambekar et al. (2006) , and the MDR isolates were recorded following Magiorakos et al. (2012) (link).
+ Open protocol
+ Expand
8

Antibiogram of Proteus mirabilis Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The disc diffusion method was carried out to investigate the antibiogram of the obtained P. mirabilis isolates using Mueller-Hinton agar (Oxoid, Hampshire, UK). Fifteen antimicrobial agents were involved; colistin sulfate (CT) (10 μg), ceftazidime (CAZ) (30 μg), amoxicillin (AMX) (10 μg), norfloxacin (NOR) (10 μg), piperacillin (PRL) (10 μg), amoxicillin-clavulanic acid (AMC) (30 μg), imipenem (IPM) (10 μg), nalidixic acid (ND) (30 μg), ampicillin (AMP) (10 μg ), cefotaxime (30 μg) (CTX), erythromycin (E) (15 μg), ampicillin-sulbactam(SAM) (30 μg), meropenem (MEM) (10 μg), trimethoprim-sulfamethoxazole (SXT) (19:1 μg), and doxycycline (DOX) (10 μg) (Oxoid, UK). The test was performed using E. coli-ATCC 35218 as a control strain. The diameter of the inhibition zone was estimated as described by CLSI27 . The phenotypic resistance patterns are categorized into PDR, XDR, and MDR according to Magiorakos28 (link).
+ Open protocol
+ Expand
9

Antibiotic Susceptibility of K. pneumoniae

Check if the same lab product or an alternative is used in the 5 most similar protocols
The susceptibility of K. pneumoniae isolates to different antibiotics was tested using the modified Kirby Bauer’s disc diffusion method on Mueller–Hinton agar plates (Oxoid Ltd., Basingstoke, UK). Antibiotic discs including sulfamethoxazole/trimethoprim (SXT; 25 μg), ampicillin/sulbactam (SAM; 20 μg), piperacillin/tazobactam (TZP; 110 μg), cefepime (FEP; 30 μg), ceftriaxone (CRO; 30 μg), ceftazidime (CAZ; 30 μg), cefotaxime (CTX; 30 μg), aztreonam (ATM; 30 μg), ciprofloxacin (CIP; 10 μg), levofloxacin (LEV; 10 μg), gentamicin (CN; 10 μg), amikacin (AK; 30 μg), imipenem (IPM; 10 μg), and meropenem (MEM; 10 μg) were purchased from Oxoid Ltd. (Basingstoke, UK), while CZA discs (50 μg) were obtained from Liofilchem®, Italy. The CRKP isolates were preliminary identified if they showed resistance (zone diameter ≤19 mm) to at least one of the used carbapenems (imipenem and meropenem). Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 (Naval Medical Research Unit Three, Cairo, Egypt; NAMRU-3) were included as quality control strains. All susceptibility results were interpreted as per the recommendations of the Clinical and Laboratory Standards Institute (CLSI).13
+ Open protocol
+ Expand
10

Antimicrobial Susceptibility of Cronobacter

Check if the same lab product or an alternative is used in the 5 most similar protocols
In terms of the Kirby-Bauer method, susceptibility of Cronobacter spp. isolates to the antimicrobial agents were generated by diluting the antibiotics and analyzing the sensitivity of the disk displayed in Mueller-Hinton agar (Huankai) after incubating at 37 °C for 24 h. Sixteen kinds of antimicrobial agents (AMs) (Oxoid, Hampshire, United Kingdom) were detected: Ampicillin (AMP, 10 μg), Ampicillin/sulbactam (SAM, 10 μg), Ceftazidime (CAZ, 30 μg), Cefepime (FEP, 30 μg), Ceftriaxone (CRO, 30 μg), Cefazolin (KZ, 30 μg), Cephalothin (KF, 30 μg), Gentamicin (CN, 10 μg), Tobramycin (TOB, 10 μg), Ciprofloxacin (CIP, 5 μg), Nitrofurantoin (F, 300 μg), Imipenem (IPM, 20 μg), Trimethoprim/sulfameth-oxazole (SXT, 25 μg), Aztreonam (ATM, 30 μg), Chloramphenicol (C, 30 μg), Tetracycline (TE, 30 μg). We measured and scored the susceptibilities of the analyzed isolates by the instructions from the Clinical and Laboratory Standards Institute (Melvin et al., 2018 ).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!